Back to results
US 8,277,779 B2Granted
Compositions useful for reducing nephrotoxicity and methods of use thereof
OwnerVernon D. Roweinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising an anionically substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.
Claims10
A pharmaceutical composition comprising a substituted cyclodextrin of the formula:
- cyclodextrin-[(O—R—Y)−(Me)+]n
- where R is selected from the group consisting of straight chained or branched C1-10 alkyl, alkenyl or alkynyl;
- Y is an anionic group selected from COO, SO3, SO4, PO3H or PO4;
- Me is a pharmaceutically acceptable cation;
- and
- n is a whole number greater than 1;
- an iodinated contrast agent selected from iohexyl, ioversol, diatrizoate meglumine and ioxaglate;
- and
- a pharmaceutically acceptable carrier;
- wherein the molar ratio of agent:cyclodextrin is from 2:1 to 50:1.
7 more elements
A method of reducing the nephrotoxicity of an iodinated contrast agent selected from iohexyl, ioversol, diatrizoate meglumine and ioxaglate comprising:
- combining said agent with a substituted cyclodextrin of the formula:
- cyclodextrin-[(O—R—Y)−(Me)+]n
- where R is selected from the group consisting of straight chained or branched C1-10 alkyl, alkenyl or alkynyl;
- Y is an anionic group selected from COO, SO3, SO4, PO3H or PO4;
- Me is a pharmaceutically acceptable cation;
- and
- n is a whole number greater than 1;
- and
- a pharmaceutically acceptable carrier, wherein the molar ratio of agent:cyclodextrin is from 2:1 to 50:1;
- and
- administering the resulting composition to a subject in need thereof.
8 more elements
Dependencies are inferred from the claim text.